Mushrooms as potential therapeutic agents in the treatment of cancer: Evaluation of anti-glioma effects of Coprinus comatus, Cantharellus cibarius, Lycoperdon perlatum and Lactarius deliciosus extracts
Open Access
- 1 January 2021
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 133, 111090
Abstract
No abstract availableKeywords
Funding Information
- Uniwersytet Medyczny w Bialymstoku (N/ST/ZB/17/004/2216)
- Uniwersytet Medyczny w Bialymstoku (N/ST/ZB/17/005/2216)
This publication has 59 references indexed in Scilit:
- Interleukins in glioblastoma pathophysiology: implications for therapyBritish Journal of Pharmacology, 2013
- Isolation and biological activity of triglycerides of the fermented mushroom of Coprinus ComatusBMC Complementary and Alternative Medicine, 2012
- Use of Gel Zymography to Examine Matrix Metalloproteinase (Gelatinase) Expression in Brain Tissue or in Primary Glial Cultures2011
- A comparative study on the antioxidant activity of methanolic extracts of Terminalia paniculata and Madhuca longifoliaFree Radicals and Antioxidants, 2011
- Thymidine Analogues for Tracking DNA SynthesisMolecules, 2011
- Ethanolic and aqueous extracts derived from Australian fungi inhibit cancer cell growth in vitroMycologia, 2011
- The Culinary-Medicinal Mushroom Coprinus comatus as a Natural Antiandrogenic ModulatorIntegrative Cancer Therapies, 2010
- Lactarane sesquiterpenoids from Lactarius subvellereus and their cytotoxicityBioorganic & Medicinal Chemistry Letters, 2010
- Antioxidant Properties of Cap and Stipe from Coprinus comatusMolecules, 2010
- Effect ofCoprinus comatuson Plasma Glucose Concentrations in MicePlanta Medica, 1984